** Shares of medical device maker Becton Dickinson BDX.N fall as much as 13.5% to an eight-year low of $179.09
** Stock set for its worst day since 1999, if losses hold
** BDX cuts annual profit forecast in anticipation of a potential hit from U.S. President Donald Trump's tariffs
** Co said it anticipates a $90 million impact from tariffs expense on China, majority of which will be weighted in Q4
** Co intends to invest $2.5 billion in U.S. manufacturing capacity over the next 5 years
** BDX, which has footprint in Mexico, Europe and Asia, will transfer its manufacturing facilities from China to South Carolina and Nebraska, CEO Thomas Polen said in a conference call
** Co expects its 2025 profit per share to be between $14.06 and $14.34, compared with $14.30 to $14.60 previously expected
** Co reports Q2 adj profit of $3.35 per share, beating estimates of $3.28
** As of last close, BDX had fallen 20.8% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.